MedPath

A Study of SCAD Using Stress Contrast Echocardiography

Not yet recruiting
Conditions
Spontaneous Coronary Artery Dissection
Registration Number
NCT07178509
Lead Sponsor
Mayo Clinic
Brief Summary

This study aims to fill knowledge gaps regarding microvascular perfusion and pressor response to stress among patients with history of spontaneous coronary artery dissection (SCAD) using stress contrast echocardiography.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
50
Inclusion Criteria
  • Adult >18 years old
  • Patient has a history of spontaneous coronary artery dissection (SCAD) OR patient is healthy with no significant medical history
Exclusion Criteria
  • Unable to give consent
  • Allergic or have a history of adverse reaction to dobutamine, the Definity® ultrasound enhancing agent, or atropine.
  • Has a known or suspected hypersensitivity to perflutren and therefore cannot be given Definity®.
  • Pregnant.
  • Unable to interrupt breastfeeding.
  • Within 3 months of a heart attack.
  • Severe aortic stenosis.
  • Severe, uncontrolled hypertension (>200/110 mmHg at baseline).

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change in Microvascular FunctionBaseline, immediately after the Stress Echocardiography

Microvascular Function will be determined by Microvascular Blood Flow (Liters/Minute). Microvascular Blood Flow will be measured by a stress echocardiogram with contrast. A higher Microvascular Blood Flow indicated better blood flow circulation.

Change in Blood PressureBaseline, immediately after the Stress Echocardiography

Change is blood pressure will be measured by a stress echocardiogram with contrast (mmHg).

Change in Heart RateBaseline, immediately after the Stress Echocardiography

Change in heart rate will be measured by a stress echocardiogram with contrast (beats per minute).

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Mayo Clinic

🇺🇸

Rochester, Minnesota, United States

Mayo Clinic
🇺🇸Rochester, Minnesota, United States
Pamela Engrav
Contact
507-255-6938
engrav.pamela@mayo.edu
Marysia S Tweet, M.D., M.S.
Principal Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.